Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kalbe Farma Tbk (KLBF) vs Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap (XIML) Price & Performance

Kalbe Farma TbkTrade
Reksa Dana Indeks Premier ETF MSCI Indonesia Large CapTrade

Price performance (Past 24H)

Key statistics

Kalbe Farma Tbk vs Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap trades at Rp185 (market cap 31.75B, 100 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 1039.4× Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap's market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 100). Which is the better fit depends on your goals.

KLBFXIML
Market Cap
33T31.75B
Volume
98.44M100
Lot
984.38K1
Turnover
70.64B18.5K
Average Price
717.58185
Value
70.64B18.5K
Indicative Equilibrium Price
720
Indicative Equilibrium Volume
43.62K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KLBF
View details

About Kalbe Farma Tbk

PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.

Read more on KLBF

About Reksa Dana Indeks Premier ETF MSCI Indonesia Large Cap

Read more on XIML